coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Foundry Healthcare Lewes PCN, Lewes · Health Inequalities Profile

    PCN U37341 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 1 GP practice

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    28,320

    Registered population

    57.1% aged 18–64

    25.6%

    Aged 65+

    ICB 21.9% · England 17.9%

    5.1%

    Ethnic minority (non-White)

    1.4% Asian · England 9.6%

    5.4%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~1,469

    Core20 residents (est.)

    Resident basis; registered basis ~1,541 · see page 3

    4,147

    Hypertension register

    +6.47% in 3 yrs · England +5.60%

    392

    SMI register

    30.9% of Lewes'

    453

    COPD register

    Reviews +49.34% in 3 yrs

    Forecast to 2030

    4,791

    Hypertension patients, 2030

    +644 on today

    62.6%

    QRISK ≥20% on statins, 2030

    +3.90pp over 3 yrs

    6.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    56.9%
    Under-80 blood pressure control trails comparators.

    Control in under-80s is 56.9% (England 67.8%; Lewes 60.9%), falling 5.8% over 2023 to 2025 (England +3.2%), which may reflect unverified treatment escalation gaps.

    53.9%
    High-risk lipid therapy below England average.

    Lipid-lowering therapy covers 53.9% of QRISK ≥ 20% patients (England 63.6%) and 57.8% in CKD (England 70.3%), which could reflect unverified recall gaps.

    79.7%
    Annual COPD and heart failure reviews.

    Annual reviews reach 79.7% in COPD (+49.3% over 2023 to 2025; England 76.4%) and 82.0% in heart failure (+63.2%; England 78.5%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    With 25.6% aged 65+, older adults and 14 care homes could shape needs

    Foundry Healthcare Lewes PCN operates as a single practice of 28,320 registered patients. Older adults aged 65+ make up 25.6% of the list (7,255 patients), compared to Lewes (25.9%), NHS Sussex Integrated Care Board (21.9%) and England (17.9%). Working-age adults account for 57.1% (Lewes 56.4%, NHS Sussex Integrated Care Board 60.5%, England 62.7%) and children 17.3% (Lewes 17.7%, NHS Sussex Integrated Care Board 17.7%, England 19.6%). Projected list growth to 2030 is 1.6% under an unverified model.

    Age profile

    0–1717.3%
    18–6457.1%
    65+25.6%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White94.9%
    Mixed2.5%
    Asian1.4%
    Other0.6%
    Black0.5%

    Older people · falls rows are Lewes local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Lewes LA)2,3592,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)80.7%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)64.1%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Lewes LA)1,1119819552024/25
    Falls deaths, all ages, per 100,000 (Lewes LA)15.214.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 5.4%, exceeding Lewes by 2.5 percentage points despite low overall deprivation

    The PCN average IMD decile is 6.6, less deprived than Lewes (6.2 decile), NHS Sussex Integrated Care Board (6.1 decile) and England (5.5 decile). However, 5.4% of registered patients fall into the Core20 cohort, exceeding Lewes (2.9%) by 2.5 percentage points, though below England (21.0%). This reflects an estimated 1,541 practice patients (about 1,500 residents), with 1 of 24 associated LSOAs in decile 2 and 0 in decile 1. This pocket of deprivation indicates outreach may need to focus specifically on the decile 2 neighbourhood.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Foundry5.4% · 1,541 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    392

    SMI register

    1.37% recorded prevalence

    137

    Learning disability register

    0.48% recorded prevalence

    14

    Care homes, 398 beds

    In the PCN catchment

    9.9%

    Provide unpaid care

    Lewes, Census 2021

    Severe mental illness prevalence is 1.4% (392 patients; Lewes 1.4%, NHS Sussex Integrated Care Board 1.1%, England 1.0%), and learning disability prevalence is 0.5% (137 patients; Lewes 0.6%, NHS Sussex Integrated Care Board 0.6%, England 0.6%). Catchment data records 14 care homes with 398 beds. Local authority data shows 9.9% unpaid carers and 15 rough sleepers, which describe the wider area rather than registered patients.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 1.4% (392 patients). Blood pressure checks reached 83.1% (England 83.4%), while BMI recording reached 78.2% (England 82.1%) despite rising +18.5 pp over 2023 to 2025 (England +5.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,147

    Hypertension register

    +6.47%

    Register growth, 3 yrs

    Lewes +5.23% · England +5.60%

    −3.52pp

    BP control, under 80

    ≤140/90 · −1.87pp aged 80+

    +644

    More patients by 2030

    Forecast 4,791 (16.44%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 14.5% (4,147 patients), below Lewes (18.1%), NHS Sussex Integrated Care Board (16.3%) and England (15.2%). While 88.9% of hypertensive patients have a recent blood pressure reading (England 90.0%), treatment to target is 61.8% (England 70.3%). Under-80 blood pressure control is 56.9% (England 67.8%), falling 5.8% over 2023 to 2025 (England +3.2%), and control at age 80+ is 72.3% (England 81.2%), falling 2.5% (England +2.2%). Slower control could reflect unverified treatment escalation gaps, which a prescribing audit would test. Hypertension control trails national benchmarks across all age groups, highlighting structured reviews for uncontrolled cohorts.

    Lipids and statins

    Lipid-lowering therapy uptake reaches 53.9% in QRISK ≥ 20% patients (England 63.6%) and 57.8% in CKD (England 70.3%). Both trail Lewes (56.2% and 64.5%) and NHS Sussex Integrated Care Board (60.0% and 65.9%). Fewer high-risk patients receive lipid-lowering therapy than benchmarks, identifying potential statin under-treatment.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202642,125£2.10£2.42£1.86£88,462
    Cardiovascular (all), 202557,918£2.78£3.32£3.33£161,012

    In 2026, the PCN prescribed 42,125 lipid-regulating drug items at £2.10 per item (England £1.86; NHS Sussex Integrated Care Board £2.42), spending £10,110 more than at England's unit cost, across 42,125 items, though unit cost does not indicate prescribing efficiency. Prescribing spend per item exceeds national rates, highlighting potential formulary review.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +31.92%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +6.16%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 1.6% (453 patients), falling 2.5% over 2023 to 2025 (England +2.6%), while 12-month COPD reviews rose +49.3% to 79.7% (England 76.4%). Asthma prevalence is 7.0% (1,921 patients), but 12-month reviews reach 56.2% (England 65.7%), leaving about 840 patients without a recorded review despite reviews rising +31.9% over 2023 to 2025 (England +4.4%). Recording second-hand smoke exposure in asthma patients aged 6-19 reached 66.8% (169 patients; England 78.8%). Prioritising routine asthma recalls and paediatric smoke recording addresses delivery shortfalls.

    Cancer register and children's immunisation

    Recorded cancer prevalence is 5.3% (1,505 patients; England 3.8%, Lewes 5.6%). In Q1 2025/26, 6-in-1 coverage at 12 months reached 97.9% (England 91.0%), exceeding the 95.0% target. However, MMR dose 1 coverage at 24 months was 90.6% (England 88.3%), and MMR dose 2 at age 5 was 91.1% (England 82.8%), both trailing the 95.0% target. Maintaining prompt recall is essential to achieve target herd immunity.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.9%

    England 91.0%

    6-in-1 complete primary course at 24 months94.3%

    England 92.2%

    MMR dose 1 at 24 months90.6%

    England 88.3%

    MMR dose 2 at age 591.1%

    England 82.8%

    4-in-1 pre-school booster at age 592.9%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    Across NHS Sussex ICB in 2022, 58.5% of cancers with a known stage were diagnosed at stage 1 or 2 (4,799 of 8,209), exceeding England (55.3%) by 3.2 percentage points and up 5 pp since 2013, but 16.5 percentage points below the 75.0% national ambition by 2028 (a gap of about 1,360 cases). Known-stage completeness was 64.3% (England 67.0%). Within Foundry Healthcare Lewes PCN, recorded cancer prevalence is 5.3% (1,505 patients; England 3.8%), with breast screening at 77.3% (England 69.9%) and cervical screening at 69.5% (Lewes 69.8%), though cervical screening fell 1.6% over 2023 to 2025 (England -1.0%). System staging data reflects wider ICB performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, University Hospitals Sussex NHS Foundation Trust achieved 65.2% on the 62-day cancer referral to treatment standard (standard 85.0%), trailing East Sussex Healthcare NHS Trust (67.0%), Maidstone and Tunbridge Wells NHS Trust (87.4%), NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%). The trust reached 74.0% on the 28-day faster diagnosis standard (standard 75.0%; England 79.3%). For diagnostics, 12.9% waited 6+ weeks across tests (England 23.1%), but colonoscopy reached 39.3% (East Sussex Healthcare NHS Trust 0.7%). These provider metrics describe acute system pressures, not PCN-specific delays.

    Pathways within standard (%)SussexEast Sussex HealthcareMaidstone and Tunbridge WellsSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0184.2081.7879.2979.32
    31-day treatment (96%)76.7998.1998.3590.4592.50
    62-day referral to treatment (85%)65.2067.0487.4371.5171.16
    Diagnostic waits over 6 weeks (%)SussexEast Sussex HealthcareMaidstone and Tunbridge WellsEngland
    MRI5.626.480.9221.40
    CT8.570.480.519.92
    Echocardiography0.3921.942.5728.48
    Colonoscopy39.350.7419.8030.83
    Gastroscopy20.020.3124.0329.02
    All 15 DM01 tests12.955.276.4223.14
    Community services activityEast Sussex residentsSurrey and Sussex ICB
    Care contacts100,740309,615
    Referrals17,28566,930
    Patients with a contact25,88085,660

    Community services (residents of East Sussex), Jun 2026 (provisional). In June 2026, East Sussex residents accounted for 100,740 community care contacts across 25,880 patients, alongside 17,285 community referrals, within NHS Surrey and Sussex Integrated Care Board's 309,615 contacts. Adults aged 65+ represented 68% of these local contacts (68,465). This experimental activity illustrates substantial community volume among older residents, though data is not available at PCN level.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Foundry2155.441.9%66.0%77.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNLewesAssetPCNLewes
    Care homes (catchment)14 (398 beds)n/aSchools (catchment)33n/a
    Children's centres12Places of worship4876
    Libraries23Homelessness support (VCS)0no data
    Primary schools (LA maintained)1316Primary academies19
    Special schoolsn/a2

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension and lipid control recall

    Under-80 BP control is 56.9% (England 67.8%), QRISK ≥ 20% lipid therapy is 53.9% (England 63.6%), and hypertension prevalence is 14.5% (4,147 patients vs Lewes 18.1%; range +166 to +981). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Asthma review and COPD audit

    Asthma reviews reach 56.2% of 1,921 patients (England 65.7%; about 840 unreviewed), age 6-19 smoke recording is 66.8% (England 78.8%), and COPD is 1.6% (453 vs Lewes 2.2%; +83 to +174). Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Inclusion health and Core20 checks

    Learning disability prevalence is 0.5% (137 patients vs Lewes and England 0.6%; range +23 to +29), and SMI BMI recording is 78.2% of 392 patients (England 82.1%) versus 83.1% for BP. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register review (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Targeted Core20 neighbourhood outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Severe mental illness check reviews (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension treatment escalation audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Childhood immunisation recall audit (p6)MMR dose 1 coverage at 24 months10YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)—PCN
    Option 1 · Hypertension and lipid control recall (p12)Registered population · Hypertension register · Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Asthma review and COPD audit (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Inclusion health and Core20 checks (p12)Registered population · Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowan · MHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15